| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | GSK 2033 |
|---|
| Description | Potent LXR antagonist (pIC50 = 7.5). Enhances T-cell proliferation and blocks T 0901317 -antiproliferative activity on T-cells. Cell permeable. Purity 99%. MW (observed): 591.66 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 2,4,6-Trimethyl-N-[[3'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]methyl]-N-[[5-(trifluoromethyl)-2-furanyl]methyl]benzenesulfonamide |
|---|
| Gene, Accession, CAS # | CAS: 1221277-90-2 |
|---|
| Catalog # | 5694/50 |
|---|
| Price | |
|---|
| Order / More Info | GSK 2033 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 23029557, 28560318 |
|---|
| 產(chǎn)品資料 |
|
|